Lineage Cell Therapeutics
LCTX
#8223
Rank
โ‚ฌ0.14 B
Marketcap
0,78ย โ‚ฌ
Share price
1.22%
Change (1 day)
-35.11%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚ฌ32.83 M

According to Lineage Cell Therapeutics 's latest financial reports the company's total liabilities are โ‚ฌ32.83 M. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lineage Cell Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ35.27 M-26.85%
2022-12-31โ‚ฌ48.22 M-34.71%
2021-12-31โ‚ฌ73.86 M608.53%
2020-12-31โ‚ฌ10.42 M-17.94%
2019-12-31โ‚ฌ12.7 M54.38%
2018-12-31โ‚ฌ8.22 M9.98%
2017-12-31โ‚ฌ7.48 M-34.76%
2016-12-31โ‚ฌ11.46 M-31.15%
2015-12-31โ‚ฌ16.65 M66.35%
2014-12-31โ‚ฌ10.01 M-10.6%
2013-12-31โ‚ฌ11.2 M171.63%
2012-12-31โ‚ฌ4.12 M22.49%
2011-12-31โ‚ฌ3.36 M16.39%
2010-12-31โ‚ฌ2.89 M73.66%
2009-12-31โ‚ฌ1.66 M-56.74%
2008-12-31โ‚ฌ3.84 M74.5%
2007-12-31โ‚ฌ2.2 M15.72%
2006-12-31โ‚ฌ1.9 M4.79%
2005-12-31โ‚ฌ1.81 M109.73%
2004-12-31โ‚ฌ0.86 M-68.81%
2003-12-31โ‚ฌ2.78 M9.02%
2002-12-31โ‚ฌ2.55 M10.43%
2001-12-31โ‚ฌ2.31 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ24.22 M-26.22%๐Ÿ‡บ๐Ÿ‡ธ USA